首页> Science translational medicine> Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".

Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".

导出 LinkOut

翻译打印收藏纠错

第一作者： Stefan,Winter

第一单位： Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Auerbachstr.112, 70376 Stuttgart, Germany.

作者： Stefan,Winter ^[1] ; Pascale,Fisel ^[1] ; Florian,Büttner ^[1] ; Anne T,Nies ^[1] ; Arnulf,Stenzl ^[2] ; Jens,Bedke ^[2] ; Matthias,Schwab ^[3] ; Elke,Schaeffeler ^[1]

作者单位： Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Auerbachstr.112, 70376 Stuttgart, Germany. ^[1] German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany.;Department of Urology, University Hospital Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany. ^[2] Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Auerbachstr.112, 70376 Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.;German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany.;Department of Clinical Pharmacology, University Hospital Tuebingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany.;Department of Pharmacy and Biochemistry, University of Tuebingen, 72076 Tuebingen, Germany. ^[3]

医学主题词癌, 肾细胞(Carcinoma, Renal Cell);表观基因组学(Epigenomics);人类(Humans);肾肿瘤(Kidney Neoplasms);有机铂化合物(Organoplatinum Compounds)

DOI 10.1126/scitranslmed.aal2439

PMID 28539468

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交